
Meera Natarajan
Examiner (ID: 11780, Phone: (571)270-3058 , Office: P/1643 )
| Most Active Art Unit | 1643 |
| Art Unit(s) | 1643 |
| Total Applications | 1062 |
| Issued Applications | 625 |
| Pending Applications | 87 |
| Abandoned Applications | 376 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 4726704
[patent_doc_number] => 20080206245
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-08-28
[patent_title] => 'COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF BREAST CANCER'
[patent_app_type] => utility
[patent_app_number] => 11/930076
[patent_app_country] => US
[patent_app_date] => 2007-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 47839
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0206/20080206245.pdf
[firstpage_image] =>[orig_patent_app_number] => 11930076
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/930076 | COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF BREAST CANCER | Oct 29, 2007 | Abandoned |
Array
(
[id] => 4697806
[patent_doc_number] => 20080219990
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-11
[patent_title] => 'COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF BREAST CANCER'
[patent_app_type] => utility
[patent_app_number] => 11/930079
[patent_app_country] => US
[patent_app_date] => 2007-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 47843
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0219/20080219990.pdf
[firstpage_image] =>[orig_patent_app_number] => 11930079
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/930079 | COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF BREAST CANCER | Oct 29, 2007 | Abandoned |
Array
(
[id] => 4697807
[patent_doc_number] => 20080219991
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-11
[patent_title] => 'COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF BREAST CANCER'
[patent_app_type] => utility
[patent_app_number] => 11/930086
[patent_app_country] => US
[patent_app_date] => 2007-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 47847
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0219/20080219991.pdf
[firstpage_image] =>[orig_patent_app_number] => 11930086
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/930086 | COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF BREAST CANCER | Oct 29, 2007 | Abandoned |
Array
(
[id] => 4726703
[patent_doc_number] => 20080206244
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-08-28
[patent_title] => 'COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF BREAST CANCER'
[patent_app_type] => utility
[patent_app_number] => 11/930073
[patent_app_country] => US
[patent_app_date] => 2007-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 47838
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0206/20080206244.pdf
[firstpage_image] =>[orig_patent_app_number] => 11930073
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/930073 | COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF BREAST CANCER | Oct 29, 2007 | Abandoned |
Array
(
[id] => 7530565
[patent_doc_number] => 07842787
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-11-30
[patent_title] => 'Biological products'
[patent_app_type] => utility
[patent_app_number] => 11/928880
[patent_app_country] => US
[patent_app_date] => 2007-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 21
[patent_no_of_words] => 10000
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/842/07842787.pdf
[firstpage_image] =>[orig_patent_app_number] => 11928880
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/928880 | Biological products | Oct 29, 2007 | Issued |
Array
(
[id] => 4697805
[patent_doc_number] => 20080219989
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-11
[patent_title] => 'COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF BREAST CANCER'
[patent_app_type] => utility
[patent_app_number] => 11/930074
[patent_app_country] => US
[patent_app_date] => 2007-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 47843
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0219/20080219989.pdf
[firstpage_image] =>[orig_patent_app_number] => 11930074
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/930074 | COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF BREAST CANCER | Oct 29, 2007 | Abandoned |
Array
(
[id] => 5969056
[patent_doc_number] => 20110150883
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-23
[patent_title] => 'COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF BREAST CANCER'
[patent_app_type] => utility
[patent_app_number] => 11/930084
[patent_app_country] => US
[patent_app_date] => 2007-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 47841
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0150/20110150883.pdf
[firstpage_image] =>[orig_patent_app_number] => 11930084
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/930084 | COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF BREAST CANCER | Oct 29, 2007 | Abandoned |
Array
(
[id] => 4758898
[patent_doc_number] => 20080311124
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-12-18
[patent_title] => 'COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF BREAST CANCER'
[patent_app_type] => utility
[patent_app_number] => 11/930077
[patent_app_country] => US
[patent_app_date] => 2007-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 47843
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0311/20080311124.pdf
[firstpage_image] =>[orig_patent_app_number] => 11930077
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/930077 | COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF BREAST CANCER | Oct 29, 2007 | Abandoned |
Array
(
[id] => 4758897
[patent_doc_number] => 20080311123
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-12-18
[patent_title] => 'COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF BREAST CANCER'
[patent_app_type] => utility
[patent_app_number] => 11/930071
[patent_app_country] => US
[patent_app_date] => 2007-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 47844
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0311/20080311123.pdf
[firstpage_image] =>[orig_patent_app_number] => 11930071
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/930071 | COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF BREAST CANCER | Oct 29, 2007 | Abandoned |
Array
(
[id] => 4726693
[patent_doc_number] => 20080206234
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-08-28
[patent_title] => 'COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF BREAST CANCER'
[patent_app_type] => utility
[patent_app_number] => 11/930083
[patent_app_country] => US
[patent_app_date] => 2007-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 47844
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0206/20080206234.pdf
[firstpage_image] =>[orig_patent_app_number] => 11930083
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/930083 | COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF BREAST CANCER | Oct 29, 2007 | Abandoned |
Array
(
[id] => 4785569
[patent_doc_number] => 20080138898
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-06-12
[patent_title] => 'METHODS FOR IMPROVING ANTIBODY PRODUCTION'
[patent_app_type] => utility
[patent_app_number] => 11/929334
[patent_app_country] => US
[patent_app_date] => 2007-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 20768
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0138/20080138898.pdf
[firstpage_image] =>[orig_patent_app_number] => 11929334
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/929334 | METHODS FOR IMPROVING ANTIBODY PRODUCTION | Oct 29, 2007 | Abandoned |
Array
(
[id] => 4915190
[patent_doc_number] => 20080095790
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-04-24
[patent_title] => 'Methods of Treating Prostate Cancer'
[patent_app_type] => utility
[patent_app_number] => 11/923289
[patent_app_country] => US
[patent_app_date] => 2007-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 7635
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0095/20080095790.pdf
[firstpage_image] =>[orig_patent_app_number] => 11923289
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/923289 | Methods of Treating Prostate Cancer | Oct 23, 2007 | Abandoned |
Array
(
[id] => 6587816
[patent_doc_number] => 20100061933
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-03-11
[patent_title] => 'PHARMACEUTICAL COMPOSITION COMPRISING ANTI-HB-EGF ANTIBODY AS ACTIVE INGREDIENT'
[patent_app_type] => utility
[patent_app_number] => 12/311960
[patent_app_country] => US
[patent_app_date] => 2007-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 32571
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0061/20100061933.pdf
[firstpage_image] =>[orig_patent_app_number] => 12311960
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/311960 | PHARMACEUTICAL COMPOSITION COMPRISING ANTI-HB-EGF ANTIBODY AS ACTIVE INGREDIENT | Oct 18, 2007 | Abandoned |
Array
(
[id] => 9977682
[patent_doc_number] => 09023993
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-05-05
[patent_title] => 'Anti-cancer agent comprising anti-HB-EGF antibody as active ingredient'
[patent_app_type] => utility
[patent_app_number] => 12/311950
[patent_app_country] => US
[patent_app_date] => 2007-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 17
[patent_no_of_words] => 24164
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 165
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12311950
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/311950 | Anti-cancer agent comprising anti-HB-EGF antibody as active ingredient | Oct 18, 2007 | Issued |
Array
(
[id] => 5289987
[patent_doc_number] => 20090022717
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-01-22
[patent_title] => 'ANTIBODIES THAT BIND CXCR7 EPITOPES'
[patent_app_type] => utility
[patent_app_number] => 11/869883
[patent_app_country] => US
[patent_app_date] => 2007-10-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 14675
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0022/20090022717.pdf
[firstpage_image] =>[orig_patent_app_number] => 11869883
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/869883 | Antibodies that bind CXCR7 epitopes | Oct 9, 2007 | Issued |
Array
(
[id] => 11873622
[patent_doc_number] => 09745380
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-08-29
[patent_title] => 'RS7 antibodies'
[patent_app_type] => utility
[patent_app_number] => 11/868290
[patent_app_country] => US
[patent_app_date] => 2007-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 20
[patent_no_of_words] => 24883
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 119
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11868290
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/868290 | RS7 antibodies | Oct 4, 2007 | Issued |
Array
(
[id] => 6467381
[patent_doc_number] => 20100040620
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-02-18
[patent_title] => 'ANTI-CANCER ANTIBODIES AGAINST LEWISy AND LEWISb ANTIGENS'
[patent_app_type] => utility
[patent_app_number] => 12/441637
[patent_app_country] => US
[patent_app_date] => 2007-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 8428
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0040/20100040620.pdf
[firstpage_image] =>[orig_patent_app_number] => 12441637
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/441637 | ANTI-CANCER ANTIBODIES AGAINST LEWISy AND LEWISb ANTIGENS | Sep 19, 2007 | Abandoned |
Array
(
[id] => 8701156
[patent_doc_number] => 08394374
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-03-12
[patent_title] => 'Optimized antibodies that target HM1.24'
[patent_app_type] => utility
[patent_app_number] => 12/441885
[patent_app_country] => US
[patent_app_date] => 2007-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 23
[patent_no_of_words] => 42009
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12441885
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/441885 | Optimized antibodies that target HM1.24 | Sep 17, 2007 | Issued |
Array
(
[id] => 6276865
[patent_doc_number] => 20100256336
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-10-07
[patent_title] => 'METHODS OF PROTEIN PURIFICATION'
[patent_app_type] => utility
[patent_app_number] => 12/441775
[patent_app_country] => US
[patent_app_date] => 2007-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 13448
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0256/20100256336.pdf
[firstpage_image] =>[orig_patent_app_number] => 12441775
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/441775 | Methods of protein production | Sep 16, 2007 | Issued |
Array
(
[id] => 4508849
[patent_doc_number] => 07915388
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-03-29
[patent_title] => 'Interleukin-13 binding proteins'
[patent_app_type] => utility
[patent_app_number] => 11/899819
[patent_app_country] => US
[patent_app_date] => 2007-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 52465
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 1087
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/915/07915388.pdf
[firstpage_image] =>[orig_patent_app_number] => 11899819
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/899819 | Interleukin-13 binding proteins | Sep 6, 2007 | Issued |